Condition
Malignant Mesothelioma
Estimated Enrollment: null
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Primary Purpose: Treatment
Study ID Numbers: MSKCC-01084|CDR0000069034|PMAR-ET-B-020-99|NCI-G01-2026
Study First Received: December 7, 2001
Last Updated: February 23, 2015
Estimated Primary Completion Date: February 2002
Primary Outcome Measures:
Sponsors and Collaborators:
PharmaMar|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00027508
